| http://www.w3.org/ns/prov#value | - Accordingly, the subject invention contemplates treating Fabry disease or other diseases resulting from a deficiency of ??-galactosidase A in mammals by administering a pharmaceutical composition containing a pharmaceutically effective amount of recombinant ??-galactosidase A or an active fragment or derivative thereof.
|
